The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever
Abstract
Background: The role of viruses in the aetiology of both chronic fatigue syndrome (CFS) and depressive illness is uncertain. Method: A prospective cohort study of 250 primary care patients, presenting with glandular fever or an ordinary upper respiratory tract infection (URTI). Results: The incidence of an acute fatigue syndrome was 47% at onset, after glandular fever, compared with 20% with an ordinary URTI (relative risk 2.3, 95% CI 1.3–4.1). The acute fatigue syndrome lasted a median (interquartile range) of eight weeks (4–16) after glandular fever, but only three weeks (2–4) after an URTI. The prevalence of CFS was 9–22% six months after glandular fever, compared with 0–6% following an ordinary URTI, with relative risks of 2.7–5.1. The most conservative measure of the incidence of CFS was 9% after glandular fever, compared with no cases after an URTI. A conservative estimate is that glandular fever accounts for 3113 (95% C11698–4528) new cases of CFS per annum in England and Wales. New episodes of major depressive disorder were triggered by infection, especially the Epstein – Barr virus, but lasted a median of only three weeks. No psychiatric disorder was significantly more prevalent six months after onset than before. Conclusions: Glandular fever is a significant risk factor for both acute and chronic fatigue syndromes. Transient new major depressive disorders occur close to onset, but are not related to any particular infection if they last more than a month.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., Komaroff, A., & and International Chronic Fatigue Syndrome Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00009 · Cited by 4,969
A report—Chronic fatigue syndrome: Guidelines for research
Sharpe, M. C. (1991) · Journal of the Royal Society of Medicine · doi:10.1177/014107689108400224 · Cited by 1,026
Chronic Fatigue and its Syndromes
Wessely, P. S., Hotopf, D. M., & Sharpe, D. M. (1998) · doi:10.1093/oso/9780192621818.001.0001 · Cited by 407
Cited by
Holmes, E. A., O'Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., Ballard, C., Christensen, H., Cohen Silver, R., Everall, I., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30168-1 · Cited by 5,715
“[115] [116] [117] Candidate biomarkers need to be evaluated to measure the effects of SARS-CoV-2 infection on the human brain and brainstem in living patients, including structural and functional MRI, diffusion-weighted MRI, quantitative cerebral blood flow imaging, and magnetic resonance spectroscopy.”
BackgroundHickie, I., Davenport, T., Wakefield, D., Vollmer-Conna, U., Cameron, B., Vernon, S. D., Reeves, W. C., & Lloyd, A. (2006) · BMJ · doi:10.1136/bmj.38933.585764.ae · Cited by 822
Unexplained post-acute infection syndromes
Choutka, J., Jansari, V., Hornig, M., & Iwasaki, A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01810-6 · Cited by 604
Prevalence and Incidence of Chronic Fatigue Syndrome in Wichita, Kansas
Reyes, M., Nisenbaum, R., Hoaglin, D. C., Unger, E. R., Emmons, C., Randall, B., Stewart, J. A., Abbey, S., Jones, J. F., Gantz, N., et al. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1530 · Cited by 439
Epstein-Barr virus—recent advances
Macsween, K. F., & Crawford, D. H. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00543-7 · Cited by 344
Self-citationThe Neuroendocrinology of Chronic Fatigue Syndrome
Cleare, A. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0014 · Cited by 315
Childhood Abuse and Later Medical Disorders in Women
Romans, S., Belaise, C., Martin, J., Morris, E., & Raffi, A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000056281 · Cited by 263
Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
Komaroff, A. L., & Bateman, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.606824 · Cited by 259
Chronic fatigue syndrome after infectious mononucleosis in adolescents
Katz, B. Z., Shiraishi, Y., Mears, C. J., Binns, H. J., & Taylor, R. (2009) · PEDIATRICS · doi:10.1542/peds.2008-1879 · Cited by 221
Gut inflammation in chronic fatigue syndrome
Lakhan, S. E., & Kirchgessner, A. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-79 · Cited by 143
“For example, infectious mononucleosis has been shown to be a risk factor for developing CFS [ 11 ].”
BackgroundMacsween, K. F., Higgins, C. D., McAulay, K. A., Williams, H., Harrison, N., Swerdlow, A. J., & Crawford, D. H. (2010) · Clinical Infectious Diseases · doi:10.1086/650456 · Cited by 74
Self-citationCytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue
Broderick, G., Katz, B. Z., Fernandes, H., Fletcher, M. A., Klimas, N., Smith, F. A., O’Gorman, M. R., Vernon, S. D., & Taylor, R. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-191 · Cited by 72
Cognitive behavior therapy for relatively active and for passive chronic fatigue syndrome patients
Bazelmans, E., Prins, J., & Bleijenberg, G. (2006) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2006.02.001 · Cited by 25
Metadata
- Authors
- White, P. D., Thomas, J. M., Amess, J., Crawford, D. H., Grover, S. A., Kangro, H. O., & Clare, A. W.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1998-12
- Volume
- 173
- Issue
- 6
- Pages
- 475-481
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2079342484
- Cited by
- 205
- References
- 3
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.